Qiu, H., Sun, Y., Pan, Z., Zhou, J., Wang, H., Wang, X., . . . Liang, P. (2021). Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation. Clinical and translational medicine, 11(12), . doi:10.1002/ctm2.647
Chicago ZitierstilQiu, Hangyuan, et al. "Inhibition of HSC70 Alleviates Hypertrophic Cardiomyopathy Pathology in Human Induced Pluripotent Stem Cell-derived Cardiomyocytes With a MYBPC3 Mutation." Clinical and Translational Medicine 11, no. 12 (2021).
MLA ZitierstilQiu, Hangyuan, et al. "Inhibition of HSC70 Alleviates Hypertrophic Cardiomyopathy Pathology in Human Induced Pluripotent Stem Cell-derived Cardiomyocytes With a MYBPC3 Mutation." Clinical and Translational Medicine 11.12 (2021).